Shares of Cellcom Israel, Ltd. (NYSE:CEL) have received a consensus broker rating score of 5.00 (Strong Sell) from the one brokers that provide coverage for the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong sell rating.

Zacks has also assigned Cellcom Israel an industry rank of 174 out of 265 based on the ratings given to its competitors.

Separately, BidaskClub cut shares of Cellcom Israel from a “sell” rating to a “strong sell” rating in a report on Saturday, August 26th.

Cellcom Israel (NYSE CEL) traded up $0.14 during trading hours on Wednesday, hitting $9.70. 8,951 shares of the stock were exchanged, compared to its average volume of 12,956. Cellcom Israel has a 1 year low of $7.74 and a 1 year high of $11.19. The company has a current ratio of 1.44, a quick ratio of 1.41 and a debt-to-equity ratio of 1.97. The stock has a market capitalization of $961.78, a PE ratio of 29.88 and a beta of 2.08.

Several large investors have recently bought and sold shares of the company. Dimensional Fund Advisors LP lifted its position in Cellcom Israel by 0.3% during the first quarter. Dimensional Fund Advisors LP now owns 75,630 shares of the technology company’s stock valued at $777,000 after purchasing an additional 234 shares during the period. Edmond DE Rothschild Holding S.A. lifted its position in Cellcom Israel by 9.1% during the second quarter. Edmond DE Rothschild Holding S.A. now owns 37,050 shares of the technology company’s stock valued at $356,000 after purchasing an additional 3,100 shares during the period. Credit Suisse AG lifted its position in Cellcom Israel by 61.6% during the first quarter. Credit Suisse AG now owns 61,754 shares of the technology company’s stock valued at $635,000 after purchasing an additional 23,544 shares during the period. Bank of America Corp DE lifted its position in Cellcom Israel by 153.2% during the first quarter. Bank of America Corp DE now owns 47,781 shares of the technology company’s stock valued at $492,000 after purchasing an additional 28,910 shares during the period. Finally, Vanguard Group Inc. lifted its position in Cellcom Israel by 7.3% during the first quarter. Vanguard Group Inc. now owns 935,422 shares of the technology company’s stock valued at $9,617,000 after purchasing an additional 63,438 shares during the period. Hedge funds and other institutional investors own 6.97% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Cellcom Israel, Ltd. (CEL) Given Average Rating of “Strong Sell” by Brokerages” was first published by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another domain, it was illegally copied and reposted in violation of U.S. and international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/cellcom-israel-ltd-cel-given-average-rating-of-strong-sell-by-brokerages/1768474.html.

About Cellcom Israel

Cellcom Israel Ltd. is engaged in the provision of cellular telephone services. The Company offers fixed-line services. The Company operates in two segments: Cellular and Fixed-line. The cellular segment includes the cellular communications services, end user cellular equipment and supplemental services.

Get a free copy of the Zacks research report on Cellcom Israel (CEL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Cellcom Israel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellcom Israel and related companies with MarketBeat.com's FREE daily email newsletter.